(02) 9850 4000
  • Linkedin
  • Twitter
  • Linkedin
  • Twitter
We are Minomic
  • Home
  • Company
    • Management
    • Board
    • Clinical Advisory Panel
    • Shareholder Information
    • For Investors
    • Financial Statements
  • Diagnostics
  • News
  • Contact Us
Select Page
ASCO meeting abstract: Glypican-1 as a novel immunotherapeutic target in prostate cancer

ASCO meeting abstract: Glypican-1 as a novel immunotherapeutic target in prostate cancer

by Minomic | Feb 14, 2018

Facebook Twitter Google+ LinkedIn A poster on Glypican-1 as a novel immunotherapeutic target in genitourinary cancers was presented by Dr Douglas Campbell, Minomic’s head of R&D at the 2018 ASCO Genitourinary Cancers Symposium in San Francisco. Preliminary...

Recent Posts

  • Minomic and Sienna enter collaboration agreement to develop pancreatic cancer test
  • Join us for the 4th global summit on precision diagnosis and treatment of prostate cancer
  • Industry News: Australian Biotech 2030 Vision to emerge from AusBiotech CEO Policy Forum

SHAREHOLDER NEWSLETTER

Minomic Shareholder Update Q2 2019

Minomic Shareholder Update Q1 2019

ANNUAL FINANCIAL STATEMENTS

2019 Annual Report

 

 

FOR SHAREHOLDERS

Change of Address Form

ENQUIRIES

Address
Suite 2, Ground Floor, 
75 Talavera Road, 
Macquarie Park, NSW 2113, 
Australia

Phone
Intl: +612 9850 4000
Aust: 02 9850 4000
(Compare your time zone with Sydney here)

MORE INFO

Would you like to talk with Minomic about:

  • Partnering with us to take our products to your markets?
  • Investing in us?
  • Media or upcoming events?
  • Some feedback that you have?
Tweets by MinomicInt

RECENT POSTS

  • Minomic and Sienna enter collaboration agreement to develop pancreatic cancer test
  • Join us for the 4th global summit on precision diagnosis and treatment of prostate cancer
  • Industry News: Australian Biotech 2030 Vision to emerge from AusBiotech CEO Policy Forum
  • Healthcare Leadership Series: Interview with Brad Walsh
  • Minomic Signs Agreement with US Pathology Laboratory
  • Minomic Secures First Prize with MiCheck® at the 2018 Innovation & Entrepreneurship Competition for Overseas High-Level Talents in China

SHAREHOLDER NEWSLETTER

Minomic Shareholder Update Q2 2019

Minomic Shareholder Update Q1 2019

ANNUAL FINANCIAL STATEMENTS

2019 Annual Report

 

 

FOR SHAREHOLDERS

Change of Address Form

ENQUIRIES

Address
Suite 2, Ground Floor, 
75 Talavera Road, 
Macquarie Park, NSW 2113, 
Australia

Phone
Intl: +612 9850 4000
Aust: 02 9850 4000
(Compare your time zone with Sydney here)

MORE INFO

Would you like to talk with Minomic about:

  • Partnering with us to take our products to your markets?
  • Investing in us?
  • Media or upcoming events?
  • Some feedback that you have?
  • Home
  • News
  • Shareholder Information
  • Terms of Use
  • Privacy Policy
  • Contact Us
  • Linkedin
  • Twitter

COPYRIGHT 2018 | MINOMIC - ALL RIGHTS RESERVED